I have the plan documents and the written criteria, which took two calls to obtain.
I want a method I can write down and repeat, not a rule of thumb.
I would rather over-engineer this than discover a problem later, within reason.
Which parts of this are load-bearing and which parts are habit?
The short version: get the criteria, evidence each one in the record, submit with the documentation attached, and appeal a denial with the reason addressed.
Where prerequisite therapy is required, the record needs the agent, the dates, the dose and the reason it was stopped. "Tried and failed" without those four elements is not documentation.
| Line | Brand, insured | Compounded, subscription | Research-grade, self-tested |
|---|---|---|---|
| Product | Copay × 12 | Monthly fee × 12 | Vials × unit price |
| Consultation | Covered or copay | Bundled | Not applicable |
| Monitoring labs | Often covered | Usually not | Self-funded |
| Independent testing | Not applicable | Optional | Essential; per lot |
| Shipping | Pharmacy | Included | Per order |
| Dominant cost | Copay structure | Subscription fee | Testing |
Stated carefully, each criterion must be evidenced in the clinical record, dated, before the request. A criterion asserted in a covering letter but absent from the notes is the commonest reason for a denial.
Medical policies stating prior-authorisation criteria are published by plans and are obtainable before submission.
Attach everything on the first submission. Incomplete is the commonest denial.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAnswering this needs the plan, since criteria vary and a general answer is not actionable.
The denial letter states a specific reason. The appeal should address that reason first and explicitly, with the missing evidence attached, rather than restating the original case.
Submit the supporting documents with the request rather than waiting to be asked. Requests denied for insufficient information are denials that a complete submission would have avoided.
The caveat is that this is administrative navigation and nothing here is clinical or legal advice.
Diarise the renewal date the moment approval arrives.
edited 29 Mar 2025 by tadhg_o_riordan — fixed an arithmetic slip in the third paragraph
Answer first: a prior authorisation is a documentation exercise against published criteria, and it is won or lost on whether the record contains the required elements.
Obtain the medical policy for the specific drug and plan first. It lists the required diagnosis codes, thresholds, documented durations and any prerequisite therapy, and it is the checklist the reviewer works from.
Track the deadlines. Appeal windows are finite, and a well-founded appeal filed late is worth nothing at all.
Get the criteria first. A request written blind is a request written badly.
The honest answer is that the process rewards preparation and punishes improvisation.
A peer-to-peer review — the prescriber speaking to the plan's reviewer — is available in many systems and resolves a meaningful proportion of denials that a written appeal would not.
Appeal windows and renewal periods are defined in plan documents and are strictly applied.
Processes differ by jurisdiction and by plan, so any general description will be wrong somewhere.
Evidence every criterion in the dated record, not in a covering letter.
Peer-to-peer review is available in many systems and is underused.
Approvals expire. Note the renewal date when the approval arrives, because a lapse mid-treatment is administratively identical to a fresh denial.
A prescriber has to submit the request; this is a description of what makes one succeed, not a substitute for one.
The denial reason is the appeal specification. Address it directly.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.